MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.
Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.
Production of Group Specific Monoclonal Antibody to Aflatoxins and its Application to Enzyme-linked Immunosorbent Assay.
Production of monoclonal antibody to human esophageal cancer cell line.
New Monoclonal Antibody Approved to Treat Multiple Myeloma.
Production of a monoclonal antibody to cortisol: application to a direct enzyme-linked immunosorbent assay of plasma.
Production of an anti-dermatophyte monoclonal antibody and its application: immunochromatographic detection of dermatophytes.
Production of a monoclonal antibody against oxytetracycline and its application for oxytetracycline residue detection in shrimp.
Azelaic acid: Properties and mode of action.
Production of a monoclonal antibody strongly reacting with immature thymic T lymphocytes and its immunohistological application.
A monoclonal antibody to free N-acetylneuraminic acid.
Antibody response to rubella virus structural proteins in multiple sclerosis.
Intrathecal rubella-antibody synthesis in multiple sclerosis.
Anti-CD20 antibody wows in multiple sclerosis.
Thalamus pathology in multiple sclerosis: from biology to clinical application.
Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody.
Application of HPLC with ELSD detection for the assessment of azelaic acid impurities in liposomal formulation.
Monoclonal antibody to biotin.
Antibody response to arboviruses. Absence of increased response in amyotrophic lateral sclerosis and multiple sclerosis.
Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs.
Percutaneous absorption of azelaic acid in humans.
[Monoclonal antibodies for the treatment of multiple sclerosis].
Novel monoclonal antibodies for therapy of multiple sclerosis.
Production of a Chaetomium globosum enolase monoclonal antibody.
Monoclonal anti-conjugated azelaic acid antibody production: application to multiple sclerosis.
We have previously reported the existence of anti-conjugated azelaic acid (Aze A) antibodies in the serum of patients with multiple sclerosis (MS). In...
370KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.
Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.
Production of Group Specific Monoclonal Antibody to Aflatoxins and its Application to Enzyme-linked Immunosorbent Assay.
Production of monoclonal antibody to human esophageal cancer cell line.
New Monoclonal Antibody Approved to Treat Multiple Myeloma.
Production of a monoclonal antibody to cortisol: application to a direct enzyme-linked immunosorbent assay of plasma.
Production of an anti-dermatophyte monoclonal antibody and its application: immunochromatographic detection of dermatophytes.
Production of a monoclonal antibody against oxytetracycline and its application for oxytetracycline residue detection in shrimp.
Azelaic acid: Properties and mode of action.
Production of a monoclonal antibody strongly reacting with immature thymic T lymphocytes and its immunohistological application.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms
